Prior studies outside of the context of bone irradiation have validated that upregulated osteoclast activity from other pathologies such as osteoporosis, osteoarthritis, and lower back pain can modulate the expression of CGRP, SP, and/or NGF, contributing to pain sensitivity [41,42,43,44]. Here, TFF2 is linked to osteoporosis.